NTRK1 and Miyoshi myopathy: Several of the humanized IGF-1R antibodies and small receptor tyrosine kinase (RTK) inhibitors have been subjected to investigations in MM in in vitro studies, preclinical mouse models of MM, and in clinical trials (51,67,68).